Target Name: SAMD10
NCBI ID: G140700
Review Report on SAMD10 Target / Biomarker Content of Review Report on SAMD10 Target / Biomarker
SAMD10
Other Name(s): Sterile alpha motif domain containing 10 | C20orf136 | dJ591C20.7 | Sterile alpha motif domain-containing protein 10 | dJ591C20 | D930033N23Rik | SAM domain-containing protein 10 | sterile alpha motif domain containing 10 | SAM10_HUMAN

SAMD10: A Potential Drug Target and Biomarker

Sterile alpha motif (SAM) domains are a class of non-coding DNA sequences that have been identified as potential drug targets and biomarkers. SAMD10 is a SAM domain that has been identified in various organisms, including humans. This protein is involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. In this article, we will discuss the potential drug targets and biomarkers associated with SAMD10, as well as its current research status and potential future as a drug target.

Drug Targets

SAMD10 is a protein that is expressed in various tissues and cells of the body. It is involved in several cellular processes that are critical for human health, including:

1. Cell signaling: SAMD10 is a component of the Src tyrosine kinase, which is a protein that plays a role in cell signaling. This protein is involved in the regulation of cell growth, differentiation, and survival.
2. DNA replication: SAMD10 is involved in the regulation of DNA replication, which is a critical process for the development and maintenance of cellular genetic information.
3. Metabolism: SAMD10 is involved in the regulation of cellular metabolism, including the metabolism of nutrients and the production of energy.

Biomarkers

SAMD10 has been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This protein has been shown to be involved in the regulation of cellular processes that are associated with the development and progression of these diseases.

1. Cancer: SAMD10 has been shown to be involved in the regulation of cell growth and angiogenesis, which are critical processes for the development of cancer.
2. Neurodegenerative diseases: SAMD10 has been shown to be involved in the regulation of neurotransmitter synthesis and release, which is important for the treatment of neurodegenerative diseases.
3. Autoimmune diseases: SAMD10 has been shown to be involved in the regulation of immune cell function, which is important for the treatment of autoimmune diseases.

Research Status

SAMD10 is a protein that has been studied extensively in the past, with a focus on its role in cellular signaling and metabolism. Several studies have shown that SAMD10 plays a critical role in the regulation of cellular processes that are associated with human disease.

1. Cell signaling: Several studies have shown that SAMD10 is involved in the regulation of cellular signaling, including the regulation of cell growth, differentiation, and survival.
2. DNA replication: Studies have shown that SAMD10 is involved in the regulation of DNA replication, which is a critical process for the development and maintenance of cellular genetic information.
3. Metabolism: Studies have shown that SAMD10 is involved in the regulation of cellular metabolism, including the metabolism of nutrients and the production of energy.

Potential Therapeutic Strategies

SAMD10 is a protein that has been shown to be involved in several cellular processes that are critical for human health. As a result, several potential therapeutic strategies have been identified that target SAMD10.

1. Small molecule inhibitors: Researchers have identified several small molecules that have been shown to inhibit the activity of SAMD10. These molecules have been shown to be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.
2. mTOR inhibitors: Researchers have identified several compounds that have been shown to inhibit the activity of the mTOR signaling pathway, which is closely related to SAMD10. These compounds have been shown to be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.
3.

Protein Name: Sterile Alpha Motif Domain Containing 10

The "SAMD10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SAMD10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SAMD11 | SAMD12 | SAMD12-AS1 | SAMD13 | SAMD14 | SAMD15 | SAMD3 | SAMD4A | SAMD4A-AS1 | SAMD4B | SAMD5 | SAMD7 | SAMD8 | SAMD9 | SAMD9L | SAMHD1 | SAMM50 | SAMMSON | SAMSN1 | SAMSN1-AS1 | SANBR | SAP130 | SAP18 | SAP30 | SAP30-DT | SAP30BP | SAP30L | SAP30L-AS1 | SAPCD1 | SAPCD1-AS1 | SAPCD2 | SAR1A | SAR1B | SARAF | SARDH | SARM1 | SARNP | SARS1 | SARS2 | SART1 | SART3 | SASH1 | SASH3 | SASS6 | SAT1 | SAT1-DT | SAT2 | SATB1 | SATB1-AS1 | SATB2 | SATB2-AS1 | SATL1 | SAV1 | SAXO1 | SAXO2 | SAYSD1 | SBDS | SBDSP1 | SBF1 | SBF1P1 | SBF2 | SBF2-AS1 | SBK1 | SBK2 | SBK3 | SBNO1 | SBNO2 | SBSN | SBSPON | SC5D | SCAANT1 | SCAF1 | SCAF11 | SCAF4 | SCAF8 | SCAI | SCAMP1 | SCAMP1-AS1 | SCAMP2 | SCAMP3 | SCAMP4 | SCAMP5 | SCAND1 | SCAND2P | SCAND3 | SCAP | SCAPER | SCARA3 | SCARA5 | SCARB1 | SCARB2 | SCARF1 | SCARF2 | SCARNA1 | SCARNA10 | SCARNA11 | SCARNA12 | SCARNA13 | SCARNA14 | SCARNA15